Results 21 to 30 of about 28,789 (229)

Widening use of dexamethasone implant for the treatment of macular edema [PDF]

open access: yes, 2017
Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis.
Avitabile T.   +9 more
core   +2 more sources

Risk Factors for Central and Branch Retinal Vein Occlusion: A Meta-Analysis of Published Clinical Data [PDF]

open access: yes, 2014
Retinal vein occlusion (RVO) is a major cause of vision loss. Of the two main types of RVO, branch retinal vein occlusion (BRVO) is 4 to 6 times more prevalent than central retinal vein occlusion (CRVO).
Kolář Petr
core   +4 more sources

An Analysis of Optical Coherence Tomography Angiography (OCT-A) Perfusion Density Maps in Patients Treated for Retinal Vein Occlusion with Intravitreal Aflibercept

open access: yesDiagnostics, 2023
Aim: The primary goal of this study was to evaluate the reduction in non-perfusion area and improvement in blood flow as well as the reduction in retinal edema on optical coherence tomography angiography (OCT-A) in patients with retinal vein occlusion ...
Dorota Śpiewak   +3 more
doaj   +1 more source

The new complex method of treatment central retinal veinand branch of retinal vein occlusion

open access: yesБюллетень сибирской медицины, 2008
The new treatment method of central retinal vein and branch of retinal vein occlusion, consisting of epiretinal injection of gemasa combined with standard pharmacotherapy was developed.
D. V. Petrachkov
doaj   +1 more source

Henle fiber layer hemorrhage associated with combined central retinal vein occlusion and cilioretinal artery occlusion: a case report

open access: yesJournal of Medical Case Reports, 2023
Background The purpose of this study is to describe a patient who experienced simultaneous central retinal vein and cilioretinal artery occlusions, as well as perifoveal hemorrhage in the Henle fiber.
Hamid Riazi-Esfahani   +4 more
doaj   +1 more source

Central retinal artery occlusion and central retinal vein occlusion in contralateral eye

open access: yesRevista Brasileira de Oftalmologia, 2021
The case of a 55-year-old male who presented central retinal vein occlusion with marked macular ischemia in left eye is reported. Despite the intervention with sustained-release dexamethasone polymer injection and other clinical measures, the visual ...
Felipe Beltrão de Medeiros   +4 more
doaj   +1 more source

Central retinal vein occlusion and branch retinal vein occlusion in the same eye

open access: yesIndian Journal of Ophthalmology, 2019
M Dheepak Sundar   +3 more
doaj   +3 more sources

Combined central retinal vein occlusion and branch retinal artery occlusion

open access: yesIndian Journal of Ophthalmology, 2018
Sugandha Goel, Kumar Saurabh, Rupak Roy
doaj   +3 more sources

Fingolimod: therapeutic mechanisms and ocular adverse effects. [PDF]

open access: yes, 2017
Fingolimod is an oral immunomodulating drug used in the management of relapsing-remitting multiple sclerosis (RRMS). We aim to review the published literature on ocular manifestations of fingolimod therapy and their possible underlying mechanisms.
A Groves   +40 more
core   +1 more source

association oF systemic Diseases witH retinal vein occlusive Disease

open access: yesJournal of Nepal Medical Association, 2006
Retinal vein occlusion (RVO) is the second commonest vascular disease of the eye, second only to Diabetic Retinopathy. The association of the retinal vein occlusion with other systemic disease likes hypertension, diabetes mellitus and others has been ...
Rajesh Kishor Shrestha   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy